Potential use of antiviral l(−)nucleoside analogues for the prevention or treatment of viral associated cancers

This publication has 15 references indexed in Scilit:

• Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model
  Antimicrobial Agents and Chemotherapy, 2000
• Sensitivity of l-(-)2′,3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues
  Biochemical Pharmacology, 1999
• Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria
  Journal of Biological Chemistry, 1999
• Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β- l (−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus β- d (+) Nucleoside Analogs In Vitro
  Antimicrobial Agents and Chemotherapy, 1998
• Anti-Hepatitis B Virus Activity and Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β- l (−)-5-Fluorocytidine
  Antimicrobial Agents and Chemotherapy, 1998
• Role of Additional Mutations outside the YMDD Motif of Hepatitis B Virus Polymerase in l(−)SddC (3TC) Resistance
  Biochemical Pharmacology, 1998
• Synthesis and Anti-Hepatitis B Virus Activity of 9-(2-Deoxy-2-fluoro-β-l-arabinofuranosyl)purine Nucleosides
  Journal of Medicinal Chemistry, 1997
• Design and Synthesis of 2‘,3‘-Dideoxy- 2‘,3‘-didehydro-β-l-cytidine (β-l-d4C) and 2‘,3‘-Dideoxy-2‘,3‘-didehydro-β-l-5- fluorocytidine (β-l-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in Vitro
  Journal of Medicinal Chemistry, 1996
• Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
  Published by Elsevier ,1992
• Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
  Proceedings of the National Academy of Sciences, 1991